Anna Tosi

851 total citations
42 papers, 478 citations indexed

About

Anna Tosi is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Anna Tosi has authored 42 papers receiving a total of 478 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 9 papers in Immunology and 8 papers in Molecular Biology. Recurrent topics in Anna Tosi's work include Cancer Immunotherapy and Biomarkers (9 papers), Immunotherapy and Immune Responses (6 papers) and CAR-T cell therapy research (5 papers). Anna Tosi is often cited by papers focused on Cancer Immunotherapy and Biomarkers (9 papers), Immunotherapy and Immune Responses (6 papers) and CAR-T cell therapy research (5 papers). Anna Tosi collaborates with scholars based in Italy, United States and France. Anna Tosi's co-authors include Antonio Rosato, M Luoni, Roberta Sommaggio, Elisa Cappuzzello, S. Fava, Angelo Tocci, Antonino De Paoli, Paola Zanovello, Alberto De Paoli and Debora Carpanese and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Scientific Reports.

In The Last Decade

Anna Tosi

39 papers receiving 471 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Tosi Italy 12 181 142 78 78 64 42 478
Tanja Reineke Switzerland 11 195 1.1× 229 1.6× 174 2.2× 57 0.7× 47 0.7× 15 624
Masaharu Nohgawa Japan 10 115 0.6× 176 1.2× 74 0.9× 51 0.7× 30 0.5× 45 380
Kirtee Rishi United States 6 123 0.7× 65 0.5× 79 1.0× 42 0.5× 60 0.9× 11 464
Ashley Weiss Canada 6 139 0.8× 109 0.8× 183 2.3× 48 0.6× 57 0.9× 7 525
Masaya Yokota Japan 11 72 0.4× 200 1.4× 79 1.0× 62 0.8× 54 0.8× 23 424
Vincent Carlier Belgium 12 46 0.3× 198 1.4× 89 1.1× 68 0.9× 86 1.3× 21 476
Yoichi Ohiro Japan 12 151 0.8× 77 0.5× 262 3.4× 47 0.6× 72 1.1× 51 576
Françoise Créchet France 11 152 0.8× 67 0.5× 213 2.7× 43 0.6× 108 1.7× 20 703
Susana L. Silva Portugal 13 72 0.4× 463 3.3× 79 1.0× 40 0.5× 36 0.6× 33 621
Lynn M. Hassman United States 12 152 0.8× 303 2.1× 92 1.2× 60 0.8× 95 1.5× 26 683

Countries citing papers authored by Anna Tosi

Since Specialization
Citations

This map shows the geographic impact of Anna Tosi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Tosi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Tosi more than expected).

Fields of papers citing papers by Anna Tosi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Tosi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Tosi. The network helps show where Anna Tosi may publish in the future.

Co-authorship network of co-authors of Anna Tosi

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Tosi. A scholar is included among the top collaborators of Anna Tosi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Tosi. Anna Tosi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bottosso, Michele, Federica Miglietta, Daniele Generali, et al.. (2025). Basal-like HR + /HER2- breast cancers show higher tumor-infiltrating lymphocytes and immune signatures with potential therapeutic implications. npj Breast Cancer. 12(1). 23–23.
2.
Zordan, Paola, Matteo Grioni, Anna Tosi, et al.. (2025). Microbiome modulation uncouples efficacy and toxicity induced by immune checkpoint blockade in mouse multiple myeloma. Nature Communications. 16(1). 10384–10384.
3.
Genova, Bruno Martorelli Di, Alessandro Sinigaglia, Luisa Barzon, et al.. (2025). On the adjuvanticity of hyaluronan: The case of a SARS-CoV-2 vaccine. Journal of Controlled Release. 382. 113674–113674.
4.
Pocaterra, Arianna, Antonio Citro, Chiara Gnasso, et al.. (2024). A preclinical mouse model of hepatic metastasis to instruct effective treatment modalities. Methods in cell biology. 190. 133–150. 1 indexed citations
5.
Griguolo, Gaia, Anna Tosi, Maria Vittoria Dieci, et al.. (2022). A comprehensive profiling of the immune microenvironment of breast cancer brain metastases. Neuro-Oncology. 24(12). 2146–2158. 24 indexed citations
6.
Tosi, Anna, Adele Ferro, Alessandro Dal Maso, et al.. (2022). 19P Gene expression profile (GEP) of extensive small-cell lung cancer (eSCLC) patients (pts) receiving first-line platinum-etoposide plus atezolizumab (PEA). Annals of Oncology. 33. S552–S552. 1 indexed citations
7.
Bonini, Maira, Gianna Serafina Monti, Matteo Pelagatti, et al.. (2022). Ragweed pollen concentration predicts seasonal rhino-conjunctivitis and asthma severity in patients allergic to ragweed. Scientific Reports. 12(1). 15921–15921. 10 indexed citations
8.
9.
Carpanese, Debora, Antonella Grigoletto, Anna Tosi, et al.. (2021). Hyaluronan is a natural and effective immunological adjuvant for protein-based vaccines. Cellular and Molecular Immunology. 18(5). 1197–1210. 28 indexed citations
10.
11.
Narducci, Maria Grazia, Anna Tosi, Alessandra Frezzolini, et al.. (2020). Reduction of T Lymphoma Cells and Immunological Invigoration in a Patient Concurrently Affected by Melanoma and Sezary Syndrome Treated With Nivolumab. Frontiers in Immunology. 11. 579894–579894. 5 indexed citations
12.
Dieci, Maria Vittoria, Valentina Guarneri, Giancarlo Bisagni, et al.. (2020). 162MO Neoadjuvant chemotherapy and immunotherapy in Luminal B BC: Results of the phase II GIADA trial. Annals of Oncology. 31. S304–S305. 6 indexed citations
13.
Tosi, Anna, et al.. (2011). Time lag between Ambrosia sensitisation and Ambrosia allergy. Swiss Medical Weekly. 141(3940). w13253–w13253. 32 indexed citations
14.
Mirone, Corrado, F Albert, Anna Tosi, et al.. (2004). Efficacy and safety of subcutaneous immunotherapy with a biologically standardized extract of Ambrosia artemisiifolia pollen: a double‐blind, placebo‐controlled study. Clinical & Experimental Allergy. 34(9). 1408–1414. 31 indexed citations
15.
Luoni, M, et al.. (2004). Retroperitoneal hemorrhage following bone marrow biopsy.. PubMed. 79(1). 70–2. 11 indexed citations
16.
Salvatore, Silvia, Sergio Finazzi, Alessandra Barassi, et al.. (2003). Low Fecal Elastase: Potentially Related to Transient Small Bowel Damage Resulting from Enteric Pathogens. Journal of Pediatric Gastroenterology and Nutrition. 36(3). 392–396. 25 indexed citations
17.
Salvatore, Silvia, Sergio Finazzi, Alessandra Barassi, et al.. (2003). Low Fecal Elastase: Potentially Related to Transient Small Bowel Damage Resulting from Enteric Pathogens. Journal of Pediatric Gastroenterology and Nutrition. 36(3). 392–396. 4 indexed citations
18.
Luoni, M, Paolo Declich, Alberto De Paoli, et al.. (1995). Bone Marrow Biopsy for the Staging of Non-Hodgkin's Lymphoma: Bilateral or Unilateral Trephine Biopsy?. Tumori Journal. 81(6). 410–413. 13 indexed citations
19.
Paoli, Antonino De, et al.. (1993). Idiopathic hypereosinophilic syndrome and "eosinophilic leukemia".. PubMed. 77(5). 430–2. 10 indexed citations
20.
Tosi, Anna, et al.. (1985). Granulocytic sarcoma without evidence of acute leukemia: 2 cases with unusual localization (uterus and breast) and 1 case with bone localization.. PubMed. 69(4). 464–96. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tanja Reineke Breakdown of academic impact, for papers by Masaharu Nohgawa Breakdown of academic impact, for papers by Kirtee Rishi Breakdown of academic impact, for papers by Ashley Weiss Breakdown of academic impact, for papers by Masaya Yokota Breakdown of academic impact, for papers by Vincent Carlier Breakdown of academic impact, for papers by Yoichi Ohiro Breakdown of academic impact, for papers by Françoise Créchet Breakdown of academic impact, for papers by Susana L. Silva Breakdown of academic impact, for papers by Lynn M. Hassman
Rankless by CCL
2026